Yumi Aoyama Yusuke Ushio Takashi Yokoyama Sekiko Taneda Shiho Makabe Miki Nishida Shun Manabe Masayo Sato Hiroshi Kataoka Ken Tsuchiya Kosaku Nitta Toshio Mochizuki
10.2169/internalmedicine.3813-19
Intern Med
2020;59(7):971-976.
fabry disease lyso-gb3 mulberry body mulberry cell enzyme replacement therapy urinary sediment
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/32238663/
Enzyme Replacement Therapy Fabry Disease / drug therapy Podocytes / pathology Urine / cytology
Enzyme Replacement Therapy Fabry Disease / drug therapy Podocytes / pathology Urine / cytology Case Reports Adult Biomarkers Fabry Disease / genetics Fabry Disease / pathology Female Genetic Testing Humans Male Microscopy, Electron Podocytes / ultrastructure alpha-Galactosidase / metabolism alpha-Galactosidase / therapeutic use Biomarkers alpha-Galactosidase
PMC7184092
32238663
Urinary Mulberry Cells as a Biomarker of the Efficacy of Enzyme Replacement Therapy for Fabry Disease
2020